NextDose

A free web-based dose calculator using concentration guided dosing with Bayesian forecasting and the target concentration intervention approach
for busulfan, methotrexate, tacrolimus, warfarin, linezolid, voriconazole, gentamicin, tobramycin, amikacin, vancomycin, caffeine, mycophenolate, hydroxychloroquine, dabigatran, posaconazole, gancyclovir/valgancyclovir, clozapine and enoxaparin.

About NextDose

19-Apr-2025: NextDose Version Change to 2.4.10
- Feature: Enoxaparin model released for NextDose.

04-Apr-2025: NextDose Version Change to 2.4.01
- More specific definition of genotypes in Patient details.

10-Feb-2025: NextDose Version Change to 2.4.00
- Improved target type specification.

- Feedback, and the reporting of any issues encountered, is always appreciated.

NextDose Updates
Anyone may sign up for single user access. Access to share patient data within a secure group can be applied for here.

Note that patient data stored on dev.nextdose.org is not transferable to www.nextdose.org. The dev.nextdose.org web is under active development and may change without notice as features are tested and bugs fixed.